Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema. 23/12/2014

Cunha-Vaz J1, Ashton P2, Iezzi R3, Campochiaro P4, Dugel PU5, Holz FG6, Weber M7, Danis RP8, Kuppermann BD9, Bailey C10, Billman K11, Kapik B11, Kane F12, Green K11; FAME Study Group. Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema. Ophthalmology. 2014 Oct;121(10):1892-903. doi: 10.1016/j.ophtha.2014.04.019. Epub 2014 Jun 14. http://www.ncbi.nlm.nih.gov/pubmed/24935282